Basics |
Company: |
Bio-Rad Laboratories, Inc.Class A |
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Life Sciences Tools and Services |
Market Cap: |
$9.25B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$2.51 | 1.12%
|
Avg Daily Range (30 D): |
$4.91 | 1.47%
|
Avg Daily Range (90 D): |
$4.70 | 1.40%
|
Institutional Daily Volume |
Avg Daily Volume: |
.11M |
Avg Daily Volume (30 D): |
.09M |
Avg Daily Volume (90 D): |
.15M |
Trade Size |
Avg Trade Size (Sh.): |
54 |
Avg Trade Size (Sh.) (30 D): |
23 |
Avg Trade Size (Sh.) (90 D): |
27 |
Institutional Trades |
Total Inst.Trades: |
3,905 |
Avg Inst. Trade: |
$8.98M |
Avg Inst. Trade (30 D): |
$10.28M |
Avg Inst. Trade (90 D): |
$19.94M |
Avg Inst. Trade Volume: |
.03M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$11.21M |
Avg Closing Trade (30 D): |
$8.44M |
Avg Closing Trade (90 D): |
$18.73M |
Avg Closing Volume: |
31.08K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-27.74
|
$23.37
|
$-76.26
|
Diluted EPS
|
$-27.75
|
$23.34
|
$-76.26
|
Revenue
|
$ 2.58B
|
$ 649.73M
|
$ 638.48M
|
Gross Profit
|
$ 1.4B
|
$ 355.9M
|
$ 355.12M
|
Net Income / Loss
|
$ -778.7M
|
$ 653.17M
|
$ -2165.49M
|
Operating Income / Loss
|
$ 305.99M
|
$ 64.47M
|
$ 101.5M
|
Cost of Revenue
|
$ 1.18B
|
$ 293.83M
|
$ 283.36M
|
Net Cash Flow
|
$ -46.45M
|
$ 4.47M
|
$ -26.04M
|
PE Ratio
|
|
|
|
|